209 related articles for article (PubMed ID: 30155725)
1. [Ten key messages regarding embolic stroke of undetermined source and cryptogenic stroke].
Böttger P; Grond M; Lemm H; Buerke M
Med Klin Intensivmed Notfmed; 2018 Nov; 113(8):664-671. PubMed ID: 30155725
[TBL] [Abstract][Full Text] [Related]
2. Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS).
Diener HC; Bernstein R; Hart R
Curr Neurol Neurosci Rep; 2017 Sep; 17(9):64. PubMed ID: 28707135
[TBL] [Abstract][Full Text] [Related]
3. [ESUS (embolic stroke of undetermined sources)].
Kitagawa K
Nihon Rinsho; 2016 Apr; 74(4):597-602. PubMed ID: 27333746
[TBL] [Abstract][Full Text] [Related]
4. [Embolic stroke of undetermined source].
Vinogradov OI; Jablonskij MA; Kuznecov AN
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(12. Vyp. 2):42-48. PubMed ID: 33449532
[TBL] [Abstract][Full Text] [Related]
5. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
Ntaios G
J Am Coll Cardiol; 2020 Jan; 75(3):333-340. PubMed ID: 31976872
[TBL] [Abstract][Full Text] [Related]
6. [Past and future of the ESUS concept].
Diener HC; Endres M
Nervenarzt; 2020 Jun; 91(6):511-517. PubMed ID: 32221634
[TBL] [Abstract][Full Text] [Related]
7. Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
Diener HC; Easton JD; Granger CB; Cronin L; Duffy C; Cotton D; Brueckmann M; Sacco RL;
Int J Stroke; 2015 Dec; 10(8):1309-12. PubMed ID: 26420134
[TBL] [Abstract][Full Text] [Related]
8. Importance of Finding Embolic Sources for Patients with Embolic Stroke of Undetermined Source.
Umemura T; Nishizawa S; Nakano Y; Saito T; Kitagawa T; Miyaoka R; Suzuki K; Yamamoto J
J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1810-1815. PubMed ID: 31097326
[TBL] [Abstract][Full Text] [Related]
9. Embolic Stroke of Undetermined Source: Gateway to a New Stroke Entity?
Schäbitz WR; Köhrmann M; Schellinger PD; Minnerup J; Fisher M
Am J Med; 2020 Jul; 133(7):795-801. PubMed ID: 32247819
[TBL] [Abstract][Full Text] [Related]
10. Review and update of the concept of embolic stroke of undetermined source.
Diener HC; Easton JD; Hart RG; Kasner S; Kamel H; Ntaios G
Nat Rev Neurol; 2022 Aug; 18(8):455-465. PubMed ID: 35538232
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.
Veltkamp R; Pearce LA; Korompoki E; Sharma M; Kasner SE; Toni D; Ameriso SF; Mundl H; Tatlisumak T; Hankey GJ; Lindgren A; Berkowitz SD; Arauz A; Ozturk S; Muir KW; Chamorro Á; Perera K; Shuaib A; Rudilosso S; Shoamanesh A; Connolly SJ; Hart RG
JAMA Neurol; 2020 Oct; 77(10):1233-1240. PubMed ID: 32628266
[TBL] [Abstract][Full Text] [Related]
12. Cryptogenic Stroke: Diagnostic Workup and Management.
Mac Grory B; Flood SP; Apostolidou E; Yaghi S
Curr Treat Options Cardiovasc Med; 2019 Dec; 21(11):77. PubMed ID: 31792625
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
[TBL] [Abstract][Full Text] [Related]
14. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design.
Geisler T; Poli S; Meisner C; Schreieck J; Zuern CS; Nägele T; Brachmann J; Jung W; Gahn G; Schmid E; Bäezner H; Keller T; Petzold GC; Schrickel JW; Liman J; Wachter R; Schön F; Schabet M; Lindner A; Ludolph AC; Kimmig H; Jander S; Schlegel U; Gawaz M; Ziemann U
Int J Stroke; 2017 Dec; 12(9):985-990. PubMed ID: 27881833
[TBL] [Abstract][Full Text] [Related]
15. Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice.
Grifoni E; Giglio D; Guazzini G; Cosentino E; Latini E; Dei A; Del Rosso A; Guarnaccia V; Baldini M; Bartolozzi ML; Martinucci P; Sani F; Giordano A; Dainelli F; Maggi F; Giulietti C; Romagnoli M; Cinotti S; Schipani E; Murgida GS; Di Martino S; Cozzi A; Carli Ballola A; Dacomo D; Valori D; Masotti L
J Thromb Thrombolysis; 2020 Jan; 49(1):75-85. PubMed ID: 31494844
[TBL] [Abstract][Full Text] [Related]
16. Management of Embolic Stroke of Undetermined Source (ESUS).
Geisler T; Mengel A; Ziemann U; Poli S
Drugs; 2018 Jun; 78(8):823-831. PubMed ID: 29737498
[TBL] [Abstract][Full Text] [Related]
17. [Embolic Stroke of Undetermined Source].
Hirano T
Brain Nerve; 2017 Jun; 69(6):651-656. PubMed ID: 28596467
[TBL] [Abstract][Full Text] [Related]
18. Embolic stroke of undetermined source: The role of the nonstenotic carotid plaque.
Bulwa Z; Gupta A
J Neurol Sci; 2017 Nov; 382():49-52. PubMed ID: 29111018
[TBL] [Abstract][Full Text] [Related]
19. Embolic strokes of undetermined source: the case for a new clinical construct.
Hart RG; Diener HC; Coutts SB; Easton JD; Granger CB; O'Donnell MJ; Sacco RL; Connolly SJ;
Lancet Neurol; 2014 Apr; 13(4):429-38. PubMed ID: 24646875
[TBL] [Abstract][Full Text] [Related]
20. Non vitamin K oral anticoagulants versus antiplatelets in embolic stroke of undetermined source: most updated evidence.
Chatterjee S; Dubey S; Lahiri D; Ray BK
Minerva Cardioangiol; 2019 Aug; 67(4):340-347. PubMed ID: 31220915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
